BEAM Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $12,322,894.05

Beam Therapeutics Insider Trading History Chart

Beam Therapeutics Share Price & Price History

^$47.91

▼ -0.54 (-1.11%)

As of 02/6/2023 01:00 AM ET

Days: 30 | 90 | 365

Profit From the Commercial Solar Boom?

From Investing Trends | Ad

Solar energy had its best year ever in 2021, with a record 24 gigawatts of power installed. That's enough to power 18 million homes! Analysts expect the global solar farm market to reach $356 billion by 2028. The utility segment of the solar market is expected to grow at the highest annual growth rate in the industry, especially with the many tax incentives now offered.

See What's Going on With the Solar Industry

Beam Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/26/2023	Terry-Ann Burrell	CFO	Sell	1,102	$45.16	$49,766.32	31,277
1/24/2023	Terry-Ann Burrell	CFO	Sell	14,810	$45.01	$666,598.10	31,277
1/18/2023	Terry-Ann Burrell	CFO	Sell	47,195	$45.14	$2,130,382.30	31,277
12/12/2022	Giuseppe Ciaramella	Insider	Sell	51,015	$42.70	$2,178,340.50	91,462
10/31/2022	John M Evans	CEO	Sell	30,000	$46.31	$1,389,300.00	1,058,520
8/5/2022	Fmr Llc	Insider	Sell	20,326	$60.50	$1,229,723.00
7/28/2022	John M Evans	CEO	Sell	30,000	$65.75	$1,972,500.00	1,088,520
4/28/2022	John M Evans	CEO	Sell	30,000	$37.98	$1,139,400.00	1,118,520
4/13/2022	Fmr Llc	Insider	Sell	19,466	$50.41	$981,281.06
3/31/2022	Giuseppe Ciaramella	Insider	Sell	1,859	$59.11	$109,885.49	115,614
3/31/2022	John M Evans	CEO	Sell	6,261	$59.11	$370,087.71	1,089,070
3/31/2022	Terry-Ann Burrell	CFO	Sell	1,787	$59.11	$105,629.57	38,278
12/21/2021	Giuseppe Ciaramella	Insider	Sell	25,104	$85.69	$2,151,161.76
10/6/2021	John M Evans	CEO	Sell	27,700	$83.80	$2,321,260.00
8/19/2021	John M Evans	CEO	Sell	20,000	$99.49	$1,989,800.00
7/7/2021	John M. Evans	CEO	Sell	25,000	$107.87	$2,696,750.00	1,046,525
7/6/2021	Graham K Cooper	Director	Sell	2,614	$120.61	$315,274.54
6/30/2021	Terry-Ann Burrell	CFO	Sell	30,000	$122.00	$3,660,000.00
6/28/2021	Giuseppe Ciaramella	Insider	Sell	78,580	$107.35	$8,435,563.00	123,341
6/28/2021	Graham K Cooper	Director	Sell	12,045	$106.34	$1,280,865.30	12,045
6/28/2021	Terry-Ann Burrell	CFO	Sell	45,000	$107.69	$4,846,050.00	69,809
4/21/2021	John M Evans	CEO	Sell	25,000	$70.49	$1,762,250.00	1,038,966

A gold storm is coming…

From Wall Street Watch Dogs | Ad

“We are in the early stages of a mania – the calm before the storm.”...

[Full Story]

SEC Filings (Institutional Ownership Changes) for Beam Therapeutics (NASDAQ:BEAM)

76.70% of Beam Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Beam Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/6/2023	Los Angeles Capital Management LLC	24,958	$0.98M	0.0%	+43.8%	0.035%
2/3/2023	D.A. Davidson & CO.	12,038	$0.47M	0.0%	-2.8%	0.017%
2/3/2023	Spire Wealth Management	5,465	$0.21M	0.0%	N/A	0.008%
2/2/2023	SG Americas Securities LLC	4,187	$0.16M	0.0%	-46.1%	0.006%
2/2/2023	Nisa Investment Advisors LLC	1,741	$68K	0.0%	+19.7%	0.002%
2/2/2023	ProShare Advisors LLC	14,901	$0.58M	0.0%	+7.5%	0.021%
2/1/2023	State of New Jersey Common Pension Fund D	50,970	$1.99M	0.0%	+29.5%	0.072%
2/1/2023	CWM LLC	29,888	$1.17M	0.0%	-16.4%	0.042%
2/1/2023	DekaBank Deutsche Girozentrale	45,000	$1.74M	0.0%	+80.0%	0.064%
1/30/2023	New York State Common Retirement Fund	55,407	$2.17M	0.0%	+7.2%	0.079%
1/30/2023	Sumitomo Mitsui Trust Holdings Inc.	673,690	$26.35M	0.0%	+31.9%	0.956%
1/26/2023	Strs Ohio	5,100	$0.20M	0.0%	-13.6%	0.007%
1/25/2023	K.J. Harrison & Partners Inc	8,497	$450.09M	0.1%	+30.8%	0.012%
1/24/2023	ARK Investment Management LLC	8,213,131	$321.22M	2.8%	-3.3%	11.655%
1/24/2023	Baillie Gifford & Co.	454,828	$17.79M	0.0%	+18.1%	0.645%
1/17/2023	Capital Advisors Inc. OK	108,354	$4.24M	0.1%	-1.4%	0.154%
1/17/2023	Ronald Blue Trust Inc.	579	$28K	0.0%	+623.8%	0.001%
1/12/2023	Green Alpha Advisors LLC	10,290	$0.40M	0.3%	+4.8%	0.015%
1/6/2023	Renaissance Capital LLC	23,223	$0.91M	0.7%	N/A	0.033%
12/8/2022	Bank of New York Mellon Corp	502,008	$23.92M	0.0%	+6.1%	0.712%
11/22/2022	Capital Impact Advisors LLC	11,697	$0.55M	0.6%	+31.0%	0.017%
11/16/2022	Glenmede Trust Co. NA	4,552	$0.22M	0.0%	N/A	0.006%
11/16/2022	Alphabet Inc.	321,604	$15.32M	0.8%	N/A	0.456%
11/15/2022	Alliancebernstein L.P.	70,100	$3.34M	0.0%	+0.4%	0.099%
11/15/2022	State Street Corp	2,562,409	$122.07M	0.0%	-23.2%	3.636%
11/15/2022	Mercer Global Advisors Inc. ADV	4,683	$0.22M	0.0%	N/A	0.007%
11/15/2022	Tang Capital Management LLC	50,000	$2.38M	0.3%	N/A	0.071%
11/15/2022	Twinbeech Capital LP	50,216	$2.39M	0.1%	N/A	0.071%
11/15/2022	Two Sigma Advisers LP	101,000	$4.81M	0.0%	+100.4%	0.143%
11/15/2022	Two Sigma Investments LP	198,996	$9.48M	0.0%	+436.1%	0.282%
11/15/2022	Temasek Holdings Private Ltd	2,866,268	$136.55M	0.8%	-27.6%	4.067%
11/15/2022	Trexquant Investment LP	22,234	$1.06M	0.0%	-61.5%	0.032%
11/15/2022	Tri Locum Partners LP	53,754	$2.56M	0.7%	N/A	0.076%
11/15/2022	UBS Asset Management Americas Inc.	58,790	$2.80M	0.0%	-10.1%	0.083%
11/15/2022	Vanguard Group Inc.	6,174,471	$294.15M	0.0%	+17.7%	8.762%
11/15/2022	Price T Rowe Associates Inc. MD	27,045	$1.29M	0.0%	+15.2%	0.038%
11/15/2022	Pearl River Capital LLC	15,455	$0.74M	0.1%	-14.0%	0.022%
11/15/2022	Quantamental Technologies LLC	13,354	$0.64M	0.2%	N/A	0.019%
11/15/2022	Eventide Asset Management LLC	267,025	$12.72M	0.3%	N/A	0.379%
11/15/2022	Engineers Gate Manager LP	12,025	$0.57M	0.0%	N/A	0.017%
11/15/2022	Ensign Peak Advisors Inc	13,730	$0.65M	0.0%	-81.6%	0.019%
11/15/2022	Farallon Capital Management LLC	3,631,271	$172.99M	1.0%	+4.6%	5.153%
11/15/2022	Bank of New York Mellon Corp	502,008	$23.92M	0.0%	+6.1%	0.712%
11/15/2022	Bellevue Group AG	571,721	$27.24M	0.4%	-0.2%	0.811%
11/15/2022	Belpointe Asset Management LLC	2,875	$0.14M	0.0%	N/A	0.004%
11/15/2022	BlackRock Inc.	5,365,899	$255.63M	0.0%	+4.1%	7.614%
11/15/2022	Capital Fund Management S.A.	27,396	$1.31M	0.0%	-9.3%	0.039%
11/15/2022	Commonwealth Equity Services LLC	5,070	$0.24M	0.0%	-19.5%	0.007%
11/14/2022	Royal Bank of Canada	24,576	$1.17M	0.0%	-21.9%	0.035%
11/14/2022	LMR Partners LLP	18,275	$0.87M	0.0%	+225.9%	0.026%
11/14/2022	Tudor Investment Corp Et Al	40,839	$1.95M	0.0%	N/A	0.058%
11/14/2022	Point72 Hong Kong Ltd	12,477	$0.59M	0.0%	N/A	0.018%
11/14/2022	Cubist Systematic Strategies LLC	77,102	$3.67M	0.0%	-62.3%	0.109%
11/14/2022	Guggenheim Capital LLC	87,530	$4.17M	0.0%	-9.7%	0.124%
11/14/2022	Renaissance Technologies LLC	71,300	$3.40M	0.0%	-74.5%	0.101%
11/14/2022	Verition Fund Management LLC	6,874	$0.33M	0.0%	-17.2%	0.010%
11/14/2022	Lazard Asset Management LLC	113,852	$5.42M	0.0%	+5.4%	0.162%
11/14/2022	Penserra Capital Management LLC	9,639	$0.46M	0.0%	+247.2%	0.014%
11/14/2022	Nuveen Asset Management LLC	242,957	$11.58M	0.0%	+5.9%	0.345%
11/14/2022	Canada Pension Plan Investment Board	3,499	$0.17M	0.0%	-34.0%	0.005%
11/14/2022	Itau Unibanco Holding S.A.	801	$38K	0.0%	-31.6%	0.001%
11/14/2022	MetLife Investment Management LLC	34,379	$1.64M	0.0%	+4.0%	0.049%
11/14/2022	E Fund Management Co. Ltd.	8,283	$0.40M	0.0%	-37.4%	0.012%
11/14/2022	Pictet Asset Management SA	4,213	$0.20M	0.0%	N/A	0.006%
11/10/2022	Envestnet Asset Management Inc.	5,580	$0.27M	0.0%	N/A	0.008%
11/10/2022	Evolutionary Tree Capital Management LLC	19,085	$0.91M	0.9%	-40.2%	0.027%
11/10/2022	Credit Suisse AG	57,868	$2.76M	0.0%	+6.9%	0.082%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	42,687	$2.03M	0.0%	N/A	0.061%
11/10/2022	Dimensional Fund Advisors LP	14,375	$0.69M	0.0%	-20.7%	0.020%
11/10/2022	Tower Research Capital LLC TRC	34,463	$1.64M	0.0%	+42.5%	0.049%
11/10/2022	UBS Group AG	8,159	$0.39M	0.0%	-79.4%	0.012%
11/9/2022	Massachusetts Financial Services Co. MA	19,350	$0.92M	0.0%	N/A	0.028%
11/9/2022	Zurcher Kantonalbank Zurich Cantonalbank	9,601	$0.46M	0.0%	-9.8%	0.014%
11/9/2022	California Public Employees Retirement System	129,888	$6.19M	0.0%	+46.7%	0.185%
11/8/2022	Hemenway Trust Co LLC	5,680	$0.27M	0.0%	N/A	0.008%
11/8/2022	Reynders McVeigh Capital Management LLC	74,914	$3.57M	0.3%	+10.4%	0.106%
11/8/2022	State Board of Administration of Florida Retirement System	21,030	$1M	0.0%	-17.5%	0.030%
11/8/2022	Mutual of America Capital Management LLC	21,505	$1.02M	0.0%	N/A	0.031%
11/8/2022	International Biotechnology Trust PLC	23,500	$1.12M	0.4%	+2,482.4%	0.033%
11/8/2022	New York State Common Retirement Fund	51,698	$2.46M	0.0%	+3.1%	0.073%
11/7/2022	Virtu Financial LLC	10,267	$0.49M	0.0%	N/A	0.015%
11/7/2022	Nisa Investment Advisors LLC	1,454	$64K	0.0%	+31.0%	0.002%
11/7/2022	D.A. Davidson & CO.	12,380	$0.59M	0.0%	+2.4%	0.018%
11/7/2022	Arizona State Retirement System	15,276	$0.73M	0.0%	+3.4%	0.022%
11/7/2022	Profund Advisors LLC	7,949	$0.38M	0.0%	+19.5%	0.011%
11/7/2022	ProShare Advisors LLC	13,865	$0.66M	0.0%	+3.7%	0.020%
11/4/2022	Yorktown Management & Research Co Inc	5,005	$0.24M	0.3%	N/A	0.007%
11/4/2022	Russell Investments Group Ltd.	92,061	$4.38M	0.0%	+2.0%	0.131%
11/4/2022	First Republic Investment Management Inc.	4,715	$0.23M	0.0%	N/A	0.007%
11/3/2022	Avidian Wealth Solutions LLC	9,400	$0.45M	0.0%	+54.1%	0.013%
11/3/2022	Teacher Retirement System of Texas	18,428	$0.88M	0.0%	+110.7%	0.026%
11/3/2022	The Manufacturers Life Insurance Company	25,237	$1.20M	0.0%	-1.8%	0.036%
11/3/2022	Barclays PLC	108,736	$5.18M	0.0%	+256.9%	0.155%
11/2/2022	Rockefeller Capital Management L.P.	1,228	$58K	0.0%	-28.3%	0.002%
11/2/2022	DekaBank Deutsche Girozentrale	25,000	$1.20M	0.0%	+78.6%	0.036%
11/2/2022	Los Angeles Capital Management LLC	17,357	$0.83M	0.0%	+5.2%	0.025%
11/2/2022	Victory Capital Management Inc.	21,193	$1.01M	0.0%	-1.8%	0.030%
11/1/2022	Great West Life Assurance Co. Can	2,967	$0.14M	0.0%	N/A	0.004%
10/31/2022	SG Americas Securities LLC	7,765	$0.37M	0.0%	-72.4%	0.011%
10/28/2022	State of New Jersey Common Pension Fund D	39,347	$1.87M	0.0%	-39.0%	0.056%

Data available starting January 2016

Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia; and BEAM-301, a liver-targeted development candidate for the treatment of patients with Glycogen Storage Disease Type Ia. It also develops therapies for alpha-1 antitrypsin deficiency; ocular diseases; and other liver, muscle, and central nervous system disorders. The company has an alliance with Boston Children's Hospital; a research and clinical trial collaboration agreement with Magenta Therapeutics, Inc.; license agreement with Sana Biotechnology, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration agreement with Pfizer Inc. and Apellis Pharmaceuticals, Inc.; and collaboration and license agreement with Verve Therapeutics, Inc. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.

Today's Range

Now: $47.91

$46.79

$48.38

50 Day Range

MA: $42.88

$36.73

$48.79

52 Week Range

Now: $47.91

$27.77

$80.00

Volume

931,365 shs

Average Volume

836,602 shs

Market Capitalization

$3.38 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.68

Who are the company insiders with the largest holdings of Beam Therapeutics?: Beam Therapeutics' top insider investors include:
John M Evans (CEO)
John M Evans (CEO)
Giuseppe Ciaramella (Insider)
Terry-Ann Burrell (CFO)
Graham K Cooper (Director)
Fmr Llc (Insider)
Learn More about top insider investors at Beam Therapeutics.
Who are the major institutional investors of Beam Therapeutics?: Beam Therapeutics' top institutional shareholders include:
ARK Investment Management LLC — 11.65%
Sumitomo Mitsui Trust Holdings Inc. — 0.96%
Baillie Gifford & Co. — 0.65%
Capital Advisors Inc. OK — 0.15%
New York State Common Retirement Fund — 0.08%
State of New Jersey Common Pension Fund D — 0.07%
Learn More about top institutional investors of Beam Therapeutics stock.
Which institutional investors are selling Beam Therapeutics stock?: During the previous quarter, BEAM stock was sold by these institutional investors:
ARK Investment Management LLC
CWM LLC
SG Americas Securities LLC
Capital Advisors Inc. OK
Strs Ohio
D.A. Davidson & CO.
In the last year, company insiders that have sold Beam Therapeutics company stock include:
John M Evans (CEO)
John M Evans (CEO)
Giuseppe Ciaramella (Insider)
Terry-Ann Burrell (CFO)
Learn More investors selling Beam Therapeutics stock.
Which institutional investors are buying Beam Therapeutics stock?: In the previous quarter, BEAM stock was bought by institutional investors including:
Sumitomo Mitsui Trust Holdings Inc.
Baillie Gifford & Co.
Renaissance Capital LLC
DekaBank Deutsche Girozentrale
Simplex Trading LLC
State of New Jersey Common Pension Fund D
Los Angeles Capital Management LLC
Spire Wealth Management